Journal of Vaccines and Immunology Submit Manuscript

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesYes
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editorial Board

    Pele Choi-Sing Chong
    Founder of Vaccine Research and Development Center
    National Institute of Infectious Diseases and Vaccinology
    Taiwan
    JVI

    Research Interest: Protein Engineering, Adjuvant and Vaccine Delivery Systems, Vaccinology, cGMP Quality Management, Immunology.

    More Info.
    Ernesto Oviedo-Ortas
    Clinical Sciences Expert
    Novartis Vaccines and Diagnostics
    Italy
    JVI

    Research Interest: Clinical Immunology.

    More Info.
    Hristiana Momchilova Batselova
    Medical Doctor
    Epidemiology of Infectious Diseases and Disaster Medicine
    Medical University, Plovdiv
    Bulgaria
    JVI

    Since July 2008, assistant in the Department of Epidemiology, MU- Plovdiv

    From April 2020 epidemiologist at the Hygiene and Epidemiology Department, University Hospital "St. George" EAD

    From September 2022 Acting Head of the Hygiene and Epidemiological Department, University Hospital "St. George" EAD

    On 27.12.2020 applied the first vaccine in the history of the vaccination campaign against COVID-19 in Plovdiv

    In 2021, she was part of the Ministry of Education and Culture of the Republic of Bulgaria campaign to educate teachers about vaccines against COVID-19.

    In 2021-2022 advises on vaccines againstCOVID-19 on the National Patient Helpline toll-free Organization.

    2021-2022 cooperates with the foundation "For our children"

    2021-2023 participated in expert meetings on epidemiology at the Ministry of Health of the Republic of Bulgaria.

    In 2022,  she was part of a working group at the Council of Ministers- Republic of Bulgaria.

    Member of:

    International epidemiological association (IEA) Bacti Vac Network. Bulgarian Scientific Society for Epidemiology of Infectious and Non-Infectious Diseases Bulgarian Association of Preventive Medicine. The South Bulgarian Society of Infectious Diseases, Epidemiology and Parasitology. Bulgarian Association for Prevention and Infection Control.

    Research Interests:

    Vaccines, vaccinology, infectious diseases, emerging diseases, epidemics, pandemics, COVID-19, varicella, shingles, measles.

    List of Publications:

    1. Tomov L, Chervenkov L, Miteva DG, Batselova H, Velikova T. Applications of time series analysis in epidemiology: Literature review and our experience during COVID-19 pandemic. World J Clin Cases. 2023 Oct 16;11(29):6974-6983. doi: 10.12998/wjcc.v11.i29.6974. PMID: 37946767; PMCID: PMC10631421.
    2. Mileva N, Vasilev GH, Ganev B, Chervenkov L, Batselova H, Tzotcheva I, Tomov L, Velikova T, Lazova S. Cardiovascular Manifestations of Multisystem Inflammatory Syndrome in Children: A Single-Center Bulgarian Study. Medicina (Kaunas). 2023 Dec 14;59(12):2175. doi: 10.3390/medicina59122175. PMID: 38138278; PMCID: PMC10744581.
    3. Dimitrov, G., Valkov, T., Batselova, H., Kounchev, O., Momekov, G., Argirova, R. Nationwide analysis of the impact of COVID-19 in patients with a cardiovascular, oncological or chronic pulmonary disease in the context of an Eastern European country with a low vaccination rate, Bulgaria: March 2020-April 2022 (2023) BMJ Open, 13 (8), art. no. e068431,
    4. Miteva, D., Kitanova, M., Batselova, H., Lazova, S., Chervenkov, L., Peshevska-Sekulovska, M., Sekulovski, M., Gulinac, M., Vasilev, G.V., Tomov, L., Velikova, T. The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice (2023) Vaccines, 11 (7), art. no. 1181.
    5. Ivanov N, Krastev B, Miteva DG, Batselova H, Alexandrova R, Velikova T. Effectiveness and safety of COVID-19 vaccines in patients with oncological diseases: State-of-the-art. World J Clin Oncol. 2023 Sep 24;14(9):343-356
    6. Tomov, L., Batselova, H., Lazova, S., Ganev, B., Tzocheva, I., Velikova, T. Role of children in the Bulgarian COVID-19 epidemic: A mathematical model study (2023) World Journal of Experimental Medicine, 13 (3), pp. 28-46.
    7.  Sekulovski, M. Mileva, N. Vasilev, G.V. Miteva, D. Gulinac, M. Peshevska-Sekulovska, M. Chervenkov, L. Batselova, H. Vasilev, G.H.; Tomov, L.; et al. Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination. Biomedicines 2023, 11, 2813.
    8. Slabakova, Y.; Gerasoudis, S.; Miteva, D.; Peshevska-Sekulovska, M.; Batselova, H.; Snegarova, V.; Vasilev, G.V.; Vasilev, G.H.; Sekulovski, M.; Lazova, S.; et al. SARS-CoV-2 Variant-Specific Gastrointestinal Symptoms of COVID-19: 2023 Update. Gastroenterol. Insights 2023, 14, 431-445. https://doi.org/10.3390/gastroent14040032 .
    9. Tomov, L.P., Batselova, H., Velikova, T.Changes in Patterns of Infectivity and Mortality with SARS-CoV-2 Omicron Variant in Bulgaria.Computer Science and Education in Computer Science. CSECS 2023. Lecture Notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering, vol 514. Springer, Cham. https://doi.org/10.1007/978-3-031-44668-9_15.
    10. Tomov, L.P., Batselova, H.M., Velikova, T.V. COVID-19 Delta Wave Caused Early Overburden of Hospital Capacity in the Bulgarian Healthcare System in 2021 (2022) Healthcare (Switzerland), 10 (4), art. no. 600.
    11. Tomov, L., Batselova, H., Velikova, T.V. Estimating COVID Case Fatality Rate in Bulgaria for 2020–2021(2022) Lecture Notes of the Institute for Computer Sciences, Social-Informatics and Telecommunications Engineering, LNICST, 450 LNICST, pp. 102-115.
    12. Snegarova V, Miteva D, Gulinac M, Peshevska-Sekulovska M, Batselova H, Velikova T. COVID-19 inpatients with gastrointestinal stromal tumors: Recommendations for management and vaccination. World J Gastrointest Pathophysiol 2022; 13(5): 170-177
    13. Vasilev G, Kabakchieva P, Miteva D, Batselova H, Velikova T. Effectiveness and safety of COVID-19vaccines in patients with diabetes as a factor for vaccine hesitancy. World J Diabetes 2022; 13(9): 738-751.
    14. Miteva D, Peshevska-Sekulovska M, Snegarova V, Batselova H, Alexandrova R, Velikova T. Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic. World J Virol 2022; 11(5): 221-236.
    15. Tomov L, Miteva D, Sekulovski M, Batselova H, Velikova T. Pandemic control-do's and don'ts from a control theory perspective. World Journal of Methodology 12.5 (2022): 392.
    16. Velikova, T., Kukov, A., Mihova, A., Snegarova, V., Batselova, H., Nakov, R. Gastrointestinal mucosal immunity and covid-19 (2021) World Journal of Gastroenterology, 27 (30), pp. 5047-5059.
    17. Tomov, L., Velikova, T., Batselova, H. HEALTH RISK MANAGEMENT IN KINDERGARTENS AND SCHOOLS DURING COVID-19 PANDEMIC (2021) General Medicine, 23 (6), pp. 22-27.
    18. Velikova, T., Batselova, H., Jenkov, V. IMPACT OF COVID19 PANDEMIC ON MENTAL HEALTH: A CROSSSECTIONAL SURVEY OF 1,020 BULGARIAN CITIZENS. Bulgarian Journal of Psychiatry (2020), 5 (3) , 10-18.
    19. Velikova TV, Kotsev SV, Georgiev DS, Batselova HM. Immunological aspects of COVID-19: What do we know? World J Biol Chem. 2020 Sep 27;11(2):14-29.
    20. Бацелова Х., Кеворкян А., Райчева Р., Бойкинова О., Балтаджиев И., Шопова Й., Стоилова Й. Епидемиологично проучване на хоспитализираните пациенти с варицела в Пловдивска област за периода 2000-2011г. Обща медицина, 2013, XV (3).
    21. Baltadzhiev, I., Stoilova, J., Popivanova, N., Bazelova, H. Changes in the Viral Hepatitis B (VHB) morbidity 1987-2006 (2009) Problems of Infectious and Parasitic Diseases, 37 (1), pp. 39-40. 
     
    More Info.
    Edd James
    Associate Professor
    Cancer Immunology
    University of Southampton
    UK
    JVI

    Research Interest: Antigen processing and presentation, relating to the understanding of these processes and manipulation of them in order to treat.

    More Info.
    Farhid Hemmatzadeh
    Senior Lecturer in Virology
    The University of Adelaide
    Australia
    JVI

    Research Interest: Molecular epidemiology, Development of diagnostic tests for viral disease, Cell culture, Bioinformatics.

    More Info.
    Bing Ni
    Professor
    Institute of Immunology
    PLA Third Military Medical University
    China
    JVI

    Research Interest: Epigenetic regulation of virus or autoimmune diseases on host immune cells such as Treg, Th17 and innate lymphoid cells (ILCs).

    More Info.
    Andrea Poscia
    Public Health Institute
    Catholic University of Sacred Heart of Rome
    Italy
    JVI

    Research Interest: HTA and to new communication strategies with people about vaccination, especially in consideration of the rising phenomena of anti-vaccination movements.

    More Info.
    Roman Chlibek
    Professor
    Department of Epidemiology
    University of Defence
    Czech Republic
    JVI

    Research Interest: Infection diseases prevention, epidemiology of infectious diseases, vaccination, vaccines, travel and tropical medicine.

    More Info.
    Liping Jin
    Department of Obstetrics and Gynecology
    Fudan University Shanghai Medical College
    China
    JVI

    Research Interest: The keywords of my research interest: Reproductive immunology, Thymic stromal lymphopoietin, The costimulatory signal, Trophoblast, Gamma-delta T cell, CD4+CD25bright regulatory T cell, Pregnancy, Miscarriage, The maternal-fetal immune.

    More Info.
    Min Wan
    Assistant Professor
    Karolinska Institutet
    Sweden
    JVI

    Research Interest: Inflammation, Immunology, Innate immunity, Infection, Antimicrobial peptides
    Lipid mediators.

    More Info.
    Salvatore Chirumbolo
    Professor
    Department of Pathology and Diagnostics
    University of Verona
    Italy
    JVI

    Research Interest: Allergy test in clinical diagnosis, Immunotherapy and in vitro cell assay, Anti-inflammatory properties of natural compounds, Allergy and vaccination, Basophil activation tests.

    More Info.
    Leabaneng Tawe
    Postdoctoral Research Fellow
    Research and Graduate Studies
    University of Botswana
    Botswana
    JVI

    •    Postdoctoral Research Fellow, University of Botswana, Gaborone, August 2021-Present

    •    Senior Consultant (Covid-19), Botswana Harvard AIDS Partnership, Gaborone, March 2020-Present

    •    Mentor/Advisory (Undergraduate Students), University of Botswana, Gaborone, January 2017-Present

    •    Research Laboratory Scientist, Botswana-UPenn Partnership, Gaborone, February 2015- July 2021

    •    Intern, UCSI University, Kuala Lumpur, January 2013- July 2013

    •    Research Laboratory Assistant, UCSI University, Kuala Lumpur, October 2012- December 2013

    Research Interest:  Pharmacokinetics/genomics in HIV and Malaria, HIV infection on the distribution of human papillomavirus genotypes, Pathogenesis of persistent cervicovaginal infections of oncogenic HPV genotypes, Host epigenetic changes associated with cervical cancer progression, Clinical trials work to improve meningitis outcomes in Botswana, Examining the utility of novel diagnostics to improve outcomes in HIV-associated meningitis patients, Molecular Surveillance of Plasmodium falciparum Drug Resistance Markers and Plasmodium falciparum multi drug resistance gene 1 mutations in symptomatic patients.

    Grants: Identification of differential expression of host genes in cervical cancer, U54-, U54, Co-PI and Graduate Student, 05/24/17-05/28/21 and Human papillomavirus infection in HIV-infected and HIV-uninfected women from Botswana and Kenya: HPV genetic variation by phylogenetic type. Project Leader, 2019 to 2021.

    More Info.
    Ting Wang
    Professor, School of Pharmacy
    Anhui Medical University
    China
    JVI

    Research Interest: Nanoparticles, liposomes, solid lipid naonparticles, and anhydrous reverse micelles, drug/vaccine carriers, freeze-drying of pharmaceutics, design, carrying out and analysis of in vivo tests, separation and purification of chemicals, extraction and analysis of therapeutic.

    More Info.
    Chiara Cadeddu
    Institute of Public Health
    Catholic University of Sacred Heart
    Italy
    JVI

    Research Interest: Public Health and Health Technology Assessment, particularly for vaccines. 

    More Info.
    Guoyun Chen
    Assistant Professor
    Department of Pediatrics
    University of Tennessee Health Science Center
    USA
    JVI

    Research Interest: Self-nonself discrimination in innate immunity, Host-pathogen interactions Autoimmune diseases.

    More Info.
    View more
    mendeley

    Lessons from COVID-19: Overcoming Vaccine Hesitancy for the Malaria Vaccine in Africa

    DOI Logo 10.17352/jvi.000061

    Published On: June 13, 2025 | Pages: 001 - 003

    Author(s): Audry Marorerwa*, Guy Tresor Karikera and Egide Haragirimana
    Abstract View Full Article View
    mendeley

    Post-vaccinal reactions following vaccination with the COVID-19 vaccine after first and second dose

    DOI Logo 10.17352/jvi.000060

    Published On: March 05, 2024 | Pages: 006 - 010

    Author(s): Velina Stoeva*, Rosen Mihaylov, Blagovesta Pencheva and Antoineta Mihova

    ORCID Logo  0000-0002-6239-4418

    Abstract View Full Article View
    mendeley

    Considerations for improving future pandemic responses

    DOI Logo 10.17352/jvi.000059

    Published On: February 08, 2024 | Pages: 001 - 005

    Author(s): Mikolaj Raszek*, David Cowley and Alberto Rubio-Casillas

    ORCID Logo  0009-0003-5755-3415

    Abstract View Full Article View
    mendeley

    Evaluation of Anti-SARS-CoV-2 IgG antibody response following COVISHEILD vaccination: A comparison between previously infected and non-infected cohorts

    DOI Logo 10.17352/jvi.000058

    Published On: August 19, 2023 | Pages: 030 - 036

    Author(s): Md Shakeel Ahmed*, Md Zakir Hossain, Md Mamunur Rashid, Istiak Ahmad, Md Zahirul Islam, Meherab Hossain and Hasan Rabbi

    ORCID Logo  0000-0002-3405-2146

    Abstract View Full Article View
    mendeley

    Dietary intervention in enhancing immunity of cancer patients

    DOI Logo 10.17352/jvi.000057

    Published On: August 09, 2023 | Pages: 024 - 029

    Author(s): Dietary intervention in enhancing immunity of cancer patients

    ORCID Logo  0000-0001-8856-3681

    Abstract View Full Article View
    mendeley

    Percutaneous Patent Ductus Arteriosus (PDA) closure: When and how to close Coil VS Occluder “step by step” cases report

    DOI Logo 10.17352/jvi.000056

    Published On: March 22, 2023 | Pages: 015 - 023

    Author(s): Nassime Zaoui*, Amina Boukabous, Nabil Irid, Katia Babou and Sabrina Benamara
    Abstract View Full Article View
    mendeley

    Study of adverse events following 2018 sub-national yellow fever vaccination in Ghana

    DOI Logo 10.17352/jvi.000055

    Published On: February 25, 2023 | Pages: 006 - 014

    Author(s): Douglas Adu-Fokuo, Feng Cheng*, Emily Yin and Elizabeth Giwa
    Abstract View Full Article View
    mendeley

    Alopecia areata

    DOI Logo 10.17352/jvi.000054

    Published On: February 21, 2023 | Pages: 001 - 005

    Author(s): Chieh Chen*

    ORCID Logo  0000-0001-5784-9855

    Abstract View Full Article View
    mendeley

    Characterization of enterotoxigenic Escherichia coli heat-labile toxin (LT) double mutant LTA72R/R192G as a Nontoxic and Effective Mucosal Adjuvant

    DOI Logo 10.17352/jvi.000053

    Published On: October 26, 2022 | Pages: 033 - 039

    Author(s): Li Ben-Qiang, Tao Jie, Cheng Jing-Hua, Shi Ying and Liu Hui-li*
    Abstract View Full Article View
    mendeley

    Effect of a third booster dose of COVID-19 mRNA vaccine in patients with haematological cancer after the initial two-dose vaccination - a single centre report

    DOI Logo 10.17352/jvi.000052

    Published On: August 08, 2022 | Pages: 029 - 032

    Author(s): Šušol Ondrej, Šušolová Barbora and Hájek Roman*
    Abstract View Full Article View

     

    Indexing/Archiving